男人女人午夜视频免费,免费人妻无码不卡中文字幕系,国产A级三级三级三级,成年无码aⅴ片在线观看

組織金屬蛋白酶抑制因子2(TIMP2)活性蛋白

Active Tissue Inhibitors Of Metalloproteinase 2 (TIMP2)

CSC-21K; TIMP Metallopeptidase Inhibitor 2

  • 組織金屬蛋白酶抑制因子2(TIMP2)活性蛋白產(chǎn)品包裝(模擬)
  • 組織金屬蛋白酶抑制因子2(TIMP2)活性蛋白產(chǎn)品包裝(模擬)
  • APA128Hu02.jpgFigure. SDS-PAGE
  • Certificate通過(guò)ISO 9001、ISO 13485質(zhì)量體系認(rèn)證

活性實(shí)驗(yàn)

Tissue inhibitors of metalloproteinases or TIMPs are a family of proteins that regulate the activation and proteolytic activity of the zinc enzymes known as matrix metalloproteinases (MMPs). There are four members of the family, TIMP-1, TIMP-2, TIMP-3, and TIMP-4. TIMP-2 is a non N-glycosylated protein with a molecular mass of 22 kDa produced by a wide range of cell types, which inhibits MMPs non-covalently by the formation of binary complexes. TIMP-2 also has erythroidpotentiating and cell growth promoting activities. The activity of recombinant human TIMP2 was measured by its ability to inhibit rhMMP2 cleavage of a fluorogenic peptide substrate MCA-Pro-Leu-Gly-Leu-DPA-Ala-Arg-NH2 in the assay buffer 50 mM Tris, 10 mM CaCl2, 150 mM NaCl, 0.05% (w/v) Brij-35, pH 7.5. rhMMP2 was diluted to 100 ug/ml and activated with 1 mM APMA at 37 °C for 1 hour and rhTIMP2 (MW: 51.75 KD) was diluted to different concentrations with the assay buffer. Mix 8 μl of rhTIMP2 curve dilutions, 12.8 μl of activated rhMMP-2, and 59.2 μl of assay buffer, including a control containing assay buffer and the diluted rhMMP-2 and incubate the reactions for 2 hours at 37 °C. Loading 50?μl of the incubated mixtures which were diluted five-fold in assay buffer into empty wells of a plate, and start the reaction by adding 50?μl of 20?μM substrate. Include a substrate blank containing 50?μl of assay buffer and 50?μl of 20?μM substrate. Then read at excitiation and emission wavelengths of 320 nm and 405 nm, respectively, in kinetic mode for 5 minutes. The result was shown in Figure 1 and it was obvious that recombinant human TIMP2 significantly decreased rhMMP2 activity. The inhibition IC50 was <0.04 nM.

用法

Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

儲(chǔ)存

避免反復(fù)凍融。2-8°C不超過(guò)一個(gè)月,-80°C不超過(guò)12個(gè)月。

穩(wěn)定性

熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時(shí),沒(méi)有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲(chǔ),損失率低于5%。

相關(guān)產(chǎn)品

編號(hào)適用物種:Homo sapiens (Human,人)應(yīng)用(僅供研究使用,不用于臨床診斷!)
APA128Hu02組織金屬蛋白酶抑制因子2(TIMP2)活性蛋白Cell?culture;?Activity?Assays.
APA128Hu01組織金屬蛋白酶抑制因子2(TIMP2)活性蛋白Cell?culture;?Activity?Assays.
EPA128Hu61組織金屬蛋白酶抑制因子2(TIMP2)真核蛋白Positive Control; Immunogen; SDS-PAGE; WB.
APA128Hu61組織金屬蛋白酶抑制因子2(TIMP2)活性蛋白Cell?culture;?Activity?Assays.
RPA128Hu02組織金屬蛋白酶抑制因子2(TIMP2)重組蛋白Positive Control; Immunogen; SDS-PAGE; WB.
RPA128Hu03組織金屬蛋白酶抑制因子2(TIMP2)重組蛋白Positive Control; Immunogen; SDS-PAGE; WB.
APA128Hu03組織金屬蛋白酶抑制因子2(TIMP2)活性蛋白Cell?culture;?Activity?Assays.
RPA128Hu01組織金屬蛋白酶抑制因子2(TIMP2)重組蛋白Positive Control; Immunogen; SDS-PAGE; WB.
PAA128Hu01組織金屬蛋白酶抑制因子2(TIMP2)多克隆抗體WB; IHC
PAA128Hu06組織金屬蛋白酶抑制因子2(TIMP2)多克隆抗體WB; IHC; ICC; IP.
LAA128Hu71組織金屬蛋白酶抑制因子2(TIMP2)多克隆抗體(生物素標(biāo)記)WB; IHC; ICC.
MAA128Hu22組織金屬蛋白酶抑制因子2(TIMP2)單克隆抗體WB; IHC; ICC; IP.
SEA128Hu組織金屬蛋白酶抑制因子2(TIMP2)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法)Enzyme-linked immunosorbent assay for Antigen Detection.
LMA128Hu組織金屬蛋白酶抑制因子2(TIMP2)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法)FLIA Kit for Antigen Detection.

參考文獻(xiàn)

雜志參考文獻(xiàn)
The Journal of NutritionOral Administration of 3,3′-Diindolylmethane Inhibits Lung Metastasis of 4T1 Murine Mammary Carcinoma Cells in BALB/c Mice[Nutrition&Metabolism: source]
Breast Cancer Research and TreatmentOral administration of benzyl-isothiocyanate inhibits solid tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells in BALB/c mice[SpringerLink: f3w831267267p277]
Moleculer VisionBone morphogenetic protein-2: a potential regulator in scleral remodeling[PubMed: PMC2605409]
Experimental & Translational Stroke Medicine Early outcome and blood-brain barrier integrity after co-administered thrombolysis and hyperbaric oxygenation in experimental stroke[PubMed: 21679435]
PLoS ONEA Combinatorial Relative Mass Value Evaluation of Endogenous Bioactive Proteins in Three-Dimensional Cultured Nucleus Pulposus Cells of Herniated Intervertebral Discs: Identification of Potential Target Proteins for Gene Therapeutic Approaches[Plosone: Source]
Polski Przeglad ChirurgicznyConcentration of gelatinases and their tissue inhibitors in pancreatic inflammatory and neoplastic tumors and their influence on the early postoperative course[Pubmed: 23585206]
Thromb Haemost.Analysis of the expression of nine secreted matrix metalloproteinases and their endogenous inhibitors in the brain of mice subjected to ischaemic stroke[Pubmed:24671655]
Pediatric Anesthesia?Impact of 6% hydroxyethyl starch 130/0.42 and 5% gelatin on renal function in a pediatric animal model[Pubmed:24916275]
PLOS ONEThe Complementary Effects of Atorvastatin and Exercise Treatment on the Composition and Stability of the Atherosclerotic Plaques in ApoE Knockout Mice[Pubmed:25264981]
Brain, Behavior, and ImmunityPlasma inflammatory biomarkers for Huntington’s disease patients and mouse model [Pubmed:25266150]
Mediators of InflammationMetalloproteinases and Their Tissue Inhibitors in Comparison between Different Chronic Pneumopathies in the Horse[Journals: Mi]
Brain, Behavior, and ImmunityPlasma inflammatory biomarkers for Huntington’s disease patients and mouse model[PubMed: 25266150]
physiological researchThe skin remodeling in type 1 diabetes and insulin resistance animal models[PubMed: 26047379]
Physiol ResThe skin remodeling in type 1 diabetes and insulin resistance animal models.[PubMed: 26047379]
J Periodontal Implant Sci Assessment of MMP-1, MMP-8 and TIMP-2 in experimental periodontitis treated with kaempferol[pmc:PMC4848383]
Int Wound J.From varices to venous ulceration: the story of chronic venous disease described by metalloproteinases.[Pubmed:26991748]
BMC Veterinary ResearchMetalloproteinases?and their?inhibitors?are?influenced?by?inhalative?glucocorticoid?therapy?incombination?with?environmental?dust?reduction?in?equine?recurrent airway obstruction.[pubmed:27938355]
Journal of Applied Animal ResearchHypoxia enhances secretion of matrix metalloproteinases in bovine dermal fibroblasts:an in vitro approach to bovine digital dermatitis [10.108:09712119.2017.1335208]
Cellular Physiology and BiochemistryThe MiR-495/Annexin A3/P53 Axis Inhibits the Invasion and EMT of Colorectal Cancer Cells[pubmed:29224019]
International Wound JournalFrom varices to venous ulceration: the story of chronic venous disease described by metalloproteinases[pubmed:26991748]
Journal of Applied Animal Research?Hypoxia enhances secretion of matrix metalloproteinases in bovine dermal fibroblasts: an approach to bovine digital dermatitis[10.1080:09712119.2017.1335208]
Mediators of InflammationMetalloproteinases and their Inhibitors under the Course of Immunostimulation by CPG-ODN and Specific Antigen Inhalation in Equine Asthma[]
Journal of endovascular therapy: an official journal of the International Society of Endovascular SpecialistsCorrelation of Baseline Plasma and Inguinal Connective Tissue Metalloproteinases and Their Inhibitors With Late High-Pressure Endoleak After Endovascular?…[Pubmed: 31464166]
Scientific ReportsMatrix metallopeptidase expression and modulation by transforming growth factor-β1 in equine endometrosis[Pubmed: 31980722]
MEDIATORS OF INFLAMMATIONMMP-9 Concentration in Peritoneal Fluid Is a Valuable Biomarker Associated with Endotoxemia in Equine Colic[33488296]
Calcium Binding Protein S100A16 Expedites Proliferation, Invasion and EMT Process in Gastric Cancer[34650982]